Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 2;32(1):86-104.e7.
doi: 10.1016/j.stem.2024.10.005. Epub 2024 Nov 4.

Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model

Affiliations

Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model

Antara Rao et al. Cell Stem Cell. .

Abstract

Despite strong evidence supporting the important roles of both apolipoprotein E4 (APOE4) and microglia in Alzheimer's disease (AD) pathogenesis, the effects of microglia on neuronal APOE4-related AD pathogenesis remain elusive. To examine such effects, we utilized microglial depletion in a chimeric model with induced pluripotent stem cell (iPSC)-derived human neurons in mouse hippocampus. Specifically, we transplanted homozygous APOE4, isogenic APOE3, and APOE-knockout (APOE-KO) iPSC-derived human neurons into the hippocampus of human APOE3 or APOE4 knockin mice and then depleted microglia in half of the chimeric mice. We found that both neuronal APOE and microglial presence were important for the formation of Aβ and tau pathologies in an APOE isoform-dependent manner (APOE4 > APOE3). Single-cell RNA sequencing analysis identified two pro-inflammatory microglial subtypes with elevated MHC-II gene expression enriched in chimeric mice with human APOE4 neuron transplants. These findings highlight the concerted roles of neuronal APOE, especially APOE4, and microglia in AD pathogenesis.

Keywords: APOE4; Alzheimer’s disease; RNA-seq; amyloid; chimeric disease model; iPSC; microglia; tau; transplantation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Y. Huang is a cofounder and scientific advisory board member of GABAeron, Inc.

Update of

References

    1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, and Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923. - PubMed
    1. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet 7, 180–184. 10.1038/ng0694-180. - DOI - PubMed
    1. Huang Y, and Mucke L (2012). Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204–1222. 10.1016/j.cell.2012.02.040. - DOI - PMC - PubMed
    1. Koutsodendris N, Nelson MR, Rao A, and Huang Y (2022). Apolipoprotein E and Alzheimer’s Disease: Findings, Hypotheses, and Potential Mechanisms. Annu. Rev. Pathol. Mech. Dis 17, 73–99. 10.1146/annurev-pathmechdis-030421-112756. - DOI - PubMed
    1. Long JM, and Holtzman DM (2019). Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 179, 312–339. 10.1016/j.cell.2019.09.001. - DOI - PMC - PubMed

Substances

LinkOut - more resources